vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and Strawberry Fields REIT, Inc. (STRW). Click either name above to swap in a different company.

Strawberry Fields REIT, Inc. is the larger business by last-quarter revenue ($40.1M vs $24.7M, roughly 1.6× Editas Medicine, Inc.). Strawberry Fields REIT, Inc. runs the higher net margin — 5.0% vs -22.7%, a 27.7% gap on every dollar of revenue. On growth, Strawberry Fields REIT, Inc. posted the faster year-over-year revenue change (31.5% vs -19.2%). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 20.0%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Strawberry Fields REIT, Inc. is a real estate investment trust focused on healthcare-related real estate assets. It owns, operates and manages skilled nursing facilities, senior living communities, and medical office buildings, primarily serving markets across the United States for healthcare providers and elderly care operators.

EDIT vs STRW — Head-to-Head

Bigger by revenue
STRW
STRW
1.6× larger
STRW
$40.1M
$24.7M
EDIT
Growing faster (revenue YoY)
STRW
STRW
+50.7% gap
STRW
31.5%
-19.2%
EDIT
Higher net margin
STRW
STRW
27.7% more per $
STRW
5.0%
-22.7%
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
20.0%
STRW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EDIT
EDIT
STRW
STRW
Revenue
$24.7M
$40.1M
Net Profit
$-5.6M
$2.0M
Gross Margin
Operating Margin
-31.3%
52.4%
Net Margin
-22.7%
5.0%
Revenue YoY
-19.2%
31.5%
Net Profit YoY
87.6%
37.6%
EPS (diluted)
$0.03
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
STRW
STRW
Q4 25
$24.7M
$40.1M
Q3 25
$7.5M
$39.7M
Q2 25
$3.6M
$37.9M
Q1 25
$4.7M
$37.3M
Q4 24
$30.6M
$30.5M
Q3 24
$61.0K
$29.5M
Q2 24
$513.0K
$29.3M
Q1 24
$1.1M
$27.8M
Net Profit
EDIT
EDIT
STRW
STRW
Q4 25
$-5.6M
$2.0M
Q3 25
$-25.1M
$2.0M
Q2 25
$-53.2M
$2.0M
Q1 25
$-76.1M
$1.6M
Q4 24
$-45.4M
$1.5M
Q3 24
$-62.1M
$944.0K
Q2 24
$-67.6M
$938.0K
Q1 24
$-62.0M
$746.0K
Operating Margin
EDIT
EDIT
STRW
STRW
Q4 25
-31.3%
52.4%
Q3 25
-325.4%
56.6%
Q2 25
-1440.6%
54.5%
Q1 25
-1635.1%
54.1%
Q4 24
-152.2%
51.5%
Q3 24
-107649.2%
54.4%
Q2 24
-14016.2%
52.3%
Q1 24
-5902.3%
51.3%
Net Margin
EDIT
EDIT
STRW
STRW
Q4 25
-22.7%
5.0%
Q3 25
-333.0%
5.1%
Q2 25
-1487.8%
5.2%
Q1 25
-1633.5%
4.2%
Q4 24
-148.3%
4.8%
Q3 24
-101870.5%
3.2%
Q2 24
-13178.8%
3.2%
Q1 24
-5458.1%
2.7%
EPS (diluted)
EDIT
EDIT
STRW
STRW
Q4 25
$0.03
$0.15
Q3 25
$-0.28
$0.16
Q2 25
$-0.63
$0.16
Q1 25
$-0.92
$0.13
Q4 24
$-0.55
$0.17
Q3 24
$-0.75
$0.14
Q2 24
$-0.82
$0.14
Q1 24
$-0.76
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
STRW
STRW
Cash + ST InvestmentsLiquidity on hand
$146.6M
$31.8M
Total DebtLower is stronger
$794.7M
Stockholders' EquityBook value
$27.3M
$12.1M
Total Assets
$186.5M
$885.2M
Debt / EquityLower = less leverage
65.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
STRW
STRW
Q4 25
$146.6M
$31.8M
Q3 25
$165.6M
$19.8M
Q2 25
$178.5M
$96.3M
Q1 25
$221.0M
$42.3M
Q4 24
$269.9M
$48.4M
Q3 24
$265.1M
$29.3M
Q2 24
$279.1M
$16.1M
Q1 24
$296.2M
$15.1M
Total Debt
EDIT
EDIT
STRW
STRW
Q4 25
$794.7M
Q3 25
$779.4M
Q2 25
$794.1M
Q1 25
$715.5M
Q4 24
$57.4M
$673.9M
Q3 24
$584.5M
Q2 24
$555.0M
Q1 24
$560.4M
Stockholders' Equity
EDIT
EDIT
STRW
STRW
Q4 25
$27.3M
$12.1M
Q3 25
$13.5M
$14.2M
Q2 25
$19.2M
$15.5M
Q1 25
$62.4M
$19.6M
Q4 24
$134.3M
$18.2M
Q3 24
$175.6M
$12.6M
Q2 24
$232.0M
$7.4M
Q1 24
$294.4M
$7.5M
Total Assets
EDIT
EDIT
STRW
STRW
Q4 25
$186.5M
$885.2M
Q3 25
$201.8M
$880.6M
Q2 25
$210.6M
$897.3M
Q1 25
$263.7M
$834.8M
Q4 24
$341.6M
$787.6M
Q3 24
$327.6M
$661.5M
Q2 24
$384.8M
$635.9M
Q1 24
$440.3M
$634.9M
Debt / Equity
EDIT
EDIT
STRW
STRW
Q4 25
65.64×
Q3 25
54.70×
Q2 25
51.26×
Q1 25
36.47×
Q4 24
0.43×
37.09×
Q3 24
46.34×
Q2 24
74.61×
Q1 24
74.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
STRW
STRW
Operating Cash FlowLast quarter
$-36.4M
$90.0M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
44.62×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
STRW
STRW
Q4 25
$-36.4M
$90.0M
Q3 25
$-30.8M
$20.7M
Q2 25
$-50.2M
$29.8M
Q1 25
$-47.8M
$19.0M
Q4 24
$-50.8M
$59.3M
Q3 24
$-52.6M
$11.8M
Q2 24
$-57.1M
$20.6M
Q1 24
$-49.9M
$2.1M
Free Cash Flow
EDIT
EDIT
STRW
STRW
Q4 25
$-36.4M
Q3 25
$-31.3M
Q2 25
Q1 25
$-47.9M
Q4 24
$-51.3M
Q3 24
$-55.5M
Q2 24
$-60.6M
Q1 24
$-51.7M
FCF Margin
EDIT
EDIT
STRW
STRW
Q4 25
-147.3%
Q3 25
-414.6%
Q2 25
Q1 25
-1028.6%
Q4 24
-167.6%
Q3 24
-90998.4%
Q2 24
-11804.3%
Q1 24
-4558.9%
Capex Intensity
EDIT
EDIT
STRW
STRW
Q4 25
0.2%
Q3 25
5.7%
Q2 25
0.0%
Q1 25
2.4%
Q4 24
1.8%
Q3 24
4788.5%
Q2 24
681.1%
Q1 24
164.8%
Cash Conversion
EDIT
EDIT
STRW
STRW
Q4 25
44.62×
Q3 25
10.26×
Q2 25
15.24×
Q1 25
11.97×
Q4 24
40.44×
Q3 24
12.53×
Q2 24
21.93×
Q1 24
2.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons